Yueh-Mei Hsu

Yueh-Mei Hsu is a highly qualified scientist with extensive experience in biomedical research, currently serving as Scientist II at Biomere since May 2023. Prior roles include a Scientist at STAIDSON BIOPHARMA INC from December 2020 to April 2023 and a Postdoctoral Research Fellow at the Buck Institute for Research on Aging from September 2015 to December 2020, where project leadership involved new drug treatments and IC50 determination on rapamycin mimic drugs. Earlier experience includes postdoctoral research at UT Health San Antonio and National Cheng Kung University, focusing on gene screening and tumor angiogenesis. Educational background comprises a PhD in Tumor Biology, a Master's degree in Physiology with a concentration on extracellular matrix, and a Bachelor's degree in Biology, all from National Cheng Kung University.